Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott W Biggins

Showing results (21-30 of 131) with videos related to

Pageof 14
Sort By:
Gastroenterology|January 2, 2021
Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19Meredith M Pearson, Ajit P Limaye, Scott W Biggins
Current Treatment Options in Gastroenterology|April 11, 2019
Albumin in Cirrhosis: More Than a ColloidCary H Paine, Scott W Biggins, Raimund H Pichler
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2024
Liver transplant activity for alcohol-associated hepatitis after OPTN diagnosis updatesKristina Folta, Nakia Chung, Scott W Biggins, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2015
Impact of body mass index on posttransplant outcomes reexaminedKiran M Bambha, Jennifer L Dodge, Jane Gralla, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 24, 2021
Toward Norepinephrine as a First-Line Treatment for All Hospitalized Patients With Hepatorenal SyndromeCary H Paine, Raimund H Pichler, Laura Evans, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 20, 2002
Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerationsScott W Biggins, Athena Beldecos, John M Rabkin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2006
Model for end-stage liver disease (MELD) exception for ascitesScott W Biggins, Steven Colquhoun, Robert G Gish, et al.
Digestive Diseases and Sciences|March 7, 2014
Rate and predictors of successful cardiopulmonary resuscitation in end-stage liver diseaseMatthew J Stotts, Kenneth W Hung, Alexander Benson, et al.
Journal of Hepatology|August 2, 2016
Revising metrics for aggressiveness assessment in liver transplantation centersAndrés E Ruf, Melisa Dirchwolf, Scott W Biggins, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality riskMa Somsouk, Rachel Kornfield, Eric Vittinghoff, et al.
Pageof 14

Showing results (21-30 of 131) with videos related to

Sort By:
Pageof 14
Gastroenterology|January 2, 2021
Tacrolimus: Unlikely Harmful and Perhaps Helpful in Liver Transplant Recipients with COVID-19Meredith M Pearson, Ajit P Limaye, Scott W Biggins
Current Treatment Options in Gastroenterology|April 11, 2019
Albumin in Cirrhosis: More Than a ColloidCary H Paine, Scott W Biggins, Raimund H Pichler
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|January 25, 2024
Liver transplant activity for alcohol-associated hepatitis after OPTN diagnosis updatesKristina Folta, Nakia Chung, Scott W Biggins, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 31, 2015
Impact of body mass index on posttransplant outcomes reexaminedKiran M Bambha, Jennifer L Dodge, Jane Gralla, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 24, 2021
Toward Norepinephrine as a First-Line Treatment for All Hospitalized Patients With Hepatorenal SyndromeCary H Paine, Raimund H Pichler, Laura Evans, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|April 20, 2002
Retransplantation for hepatic allograft failure: prognostic modeling and ethical considerationsScott W Biggins, Athena Beldecos, John M Rabkin, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|November 24, 2006
Model for end-stage liver disease (MELD) exception for ascitesScott W Biggins, Steven Colquhoun, Robert G Gish, et al.
Digestive Diseases and Sciences|March 7, 2014
Rate and predictors of successful cardiopulmonary resuscitation in end-stage liver diseaseMatthew J Stotts, Kenneth W Hung, Alexander Benson, et al.
Journal of Hepatology|August 2, 2016
Revising metrics for aggressiveness assessment in liver transplantation centersAndrés E Ruf, Melisa Dirchwolf, Scott W Biggins, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|February 1, 2011
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality riskMa Somsouk, Rachel Kornfield, Eric Vittinghoff, et al.
Pageof 14